US Patent 8183014 High affinity antibodies to human IL-6 receptor
Patent 8183014 was granted and assigned to Regeneron Pharmaceuticals, Inc. on May, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8183014 High affinity antibodies to human IL-6 receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
